Skip to main content
SpringerLink
Log in
Book cover

Hepatocellular Carcinoma pp 71–96Cite as

Hepatocellular Carcinoma

Role of Hepatitis Viruses and Liver Cell Dysplasia

  • Protocol

  • 443 Accesses

Part of the book series: Methods in Molecular Medicine™ ((MIMM,volume 45))

Abstract

Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver. HCC is a major problem worldwide because of its high prevalence and severe natural history and it is the major cause of cancer-related mortality in sub-Saharan Africa and in the Far East (1). HCC is the seventh most prevalent cancer in men and the ninth most common in women, with an estimated total of one million cases occurring each year (2–6). It carries a dismal overall prognosis: 92% of affected individuals will die because of their disease (3). In general, tumor incidence increases with age and occurs most often between the third and fifth decades of life (2). The distribution pattern shows striking and pronounced geographic and racial variations. The biological characteristics of this tumor vary significantly in different geographical areas, from country to country and even from one part of a country to another. Because of the widely divergent rates of HCC worldwide, it is possible to identify high-, intermediate-, and low-incidence areas. In China and south-east and sub-Saharan Africa, as many as 10–30 new cases per 100,000 males in habitants are reported each year, whereas in northern Europe, North America, and Australia, the annual rates of HCC are less than 3 cases a year per 100,000 males.

This is a preview of subscription content, log in via an institution.

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Kew, M. C. and Popper, H. (1984) Relationship between hepatocellular carcinoma and cirrhosis. Semin. Liver Dis. 4, 136–146.

    CAS  PubMed  Google Scholar 

  2. Anon. (1987) Hepatocellular cancer: differences between high and low incidence regions. [Editorial] Lancet. 2, 1183–1184.

    Google Scholar 

  3. Rustgi, V. K. (1987) Epidemiology of hepatocellular carcinoma. Gastroenterol. Clin. North. Am. 16, 545–551.

    CAS  PubMed  Google Scholar 

  4. Arya, S. C., Ashraf, S. J., Parande, C. M., Tobeiqi, M. S., and Ageel, A. R. (1988) Hepatitis B and delta markers in primary hepatocellular carcinoma patients in the Gizan area of Saudi Arabia. APMIS 3(Supp l), 30–34.

    Google Scholar 

  5. Di Bisceglie, A. M., Rustgi, V. K., Hoofnagle, J. H., Dusheiko, G. M., and Lotze, M. T. (1988) NIH conference. Hepatocellular carcinoma. Ann. Intern. Med. 108, 390–401.

    PubMed  Google Scholar 

  6. Bridbord, K. (1989) Pathogenesis and prevention of hepatocellular carcinoma. Cancer Detect. Prev. 14, 191–192.

    CAS  PubMed  Google Scholar 

  7. Curley, S. A., Levin, B., and Rich, T. A. (1995). Liver and bile ducts, in Clinical Oncology (Abeloff, M. D., Armitage, J. O., Lichter, A. S., Niederhuber, J. E., eds. ), Churchill Livingstone, London, pp.1305–1372.

    Google Scholar 

  8. Simonetti, R. G., Camma, C., Fiorello, F., Politi, F., D’Amico, G., and Pagliaro, L. (1991) Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig. Dis. Sci. 36, 962–972.

    CAS  PubMed  Google Scholar 

  9. Tsai, J. F., Chang, W. Y., Jeng, J. E., Ho, M. S., Wang, L. Y., Hsieh, M. Y., et al. (1993) Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan. J. Med. Virol. 41, 296–300.

    CAS  PubMed  Google Scholar 

  10. Colombo, M. (1995) Should patients with chronic viral hapatitis be screened for hepatocellular carcinoma? Viral Hepat. Rev. 1, 67–75.

    Google Scholar 

  11. Sherlock, S. and Dooley, J. (1997) Hepatic tumors, in Disease of the Liver and Biliary System, 10th ed., Blackwell Science, Oxford, pp. 531–559.

    Google Scholar 

  12. Kew, M. C. (1995) Cancer of the liver. Curr. Opin. Gastroenterol. 11, 202–206.

    Google Scholar 

  13. Kiyosawa, K., Sodeyama, T., Tanaka, E., Gibo, Y., Yoshizawa, K., Nakano, Y., et al. (1990) Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology. 12, 671–675.

    CAS  PubMed  Google Scholar 

  14. Tong, M. J., El-Farra, N. S., Reikes, A. R., and Co, R. L. (1995) Clinical outcomes after transfusion-associated hepatitis C. N. Engl. J. Med. 332, 1463–1466.

    CAS  Google Scholar 

  15. Tsai, J. F., Chang, W. Y., Jeng, J. E., Ho, M. S., Lin, Z. Y., and Tsai, J. H. (1994) Effects of hepatitis C and B viruses infection on the development of hepatocellular carcinoma. J. Med. Virol. 44, 92–95.

    CAS  PubMed  Google Scholar 

  16. Tsai, J. F., Jeng, J. E., Ho, M. S., Chang, W. Y., Lin, Z. Y., and Tsai, J. H. (1994) Hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Chinese: a case-control study. Int. J. Cancer. 56, 619–621.

    CAS  PubMed  Google Scholar 

  17. Tsai, J. F., Jeng, J. E., Ho, M. S., Chang, W. Y., Hsieh, M. Y., Lin, Z. Y., and Tsai, J. H. (1996) Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma. Br. J. Cancer. 73, 1498–1502.

    CAS  PubMed  Google Scholar 

  18. Sheu, J. C., Sung, J. L., Chen, D. S., Lai, M. Y., Wang, T. H., Yu, J. Y., et al. (1985) Early detection of hepatocellular carcinoma by real-time ultrasonography. A prospective study. Cancer. 56, 660–666.

    CAS  Google Scholar 

  19. Takayama, T., Makuuchi, M., Hirohashi, S., Sakamoto, M., Okazaki, N., Takayasu, K., et al. (1990) Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet. 2, 1150–1153.

    Google Scholar 

  20. Feitelson, M. A. (1986) HVB and cancer, in Concepts in Viral Pathogenesis II (Notkins, A. L. and Oldstone, M. B. A., eds. ), Springer-Verlag, New York, pp. 269–275.

    Google Scholar 

  21. Popper, H., Shafritz, D. A., and Hoofnagle, J. H. (1987) Relation of the hepatitis B virus carrier state to hepatocellular carcinoma. Hepatology. 7, 764–772.

    CAS  PubMed  Google Scholar 

  22. Ganem, D. and Varmus, H. E. (1987) The molecular biology of the hepatitis B viruses. Annu. Rev. Biochem. 56, 651–693.

    CAS  PubMed  Google Scholar 

  23. Harris, C. C. (1990) Hepatocellular carcinogenesis: recent advances and speculations. Cancer Cells. 2, 146–148.

    CAS  PubMed  Google Scholar 

  24. Wogan, G. N. (1992) Aflatoxins as risk factors for hepatocellular carcinoma in humans. Cancer Res. 52, 2114s–2118s.

    CAS  PubMed  Google Scholar 

  25. Ross, R. K., Yuan, J. M., Yu, M. C., Wogan, G. N., Qian, G. S., Tu, J. T., et al. (1992) Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet. 1, 943–946.

    Google Scholar 

  26. Kato, I., Tominaga, S., and Ikari, A. (1992) The risk and predictive factors for developing liver cancer among patients with decompensated liver cirrhosis. Jpn. J. Clin. Oncol. 22, 278–285.

    CAS  PubMed  Google Scholar 

  27. Tsukuma, H., Hiyama, T., Tanaka, S., Nakao, M., Yabuuchi, T., Kitamura, T., et al. (1993) Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N. Engl. J. Med. 328, 1797–1801.

    CAS  PubMed  Google Scholar 

  28. Ikeda, K., Saitoh, S., Koida, I., Arase, Y., Tsubota, A., Chayama, K., et al. (1993) A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology. 18, 47–53.

    CAS  PubMed  Google Scholar 

  29. Bolondi, L., Siringo, S., Rigamonti, A., Sofia, S., Gaiani, S., Zironi, G., et al. (1993) Multivariate analysis of risk factors for hepatocellular carcinoma in patients with cirrhosis. A prospective study. J. Hepatol. 18(Suppl. 1), S80.

    Google Scholar 

  30. Johnson, P. J. and Williams, R. (1987) Cirrhosis and the aetiology of hepatocellular carcinoma. J. Hepatol. 4, 140–147.

    CAS  PubMed  Google Scholar 

  31. Anthony, P. P., Vogel, C. L., and Barker, L. F. (1973) Liver cell dysplasia: a premalignant condition. J. Clin. Pathol. 26, 217–223.

    CAS  PubMed  Google Scholar 

  32. Borzio, M., Bruno, S., Roncalli, M., Mels, G. C., Ramella, G., Borzio, F., et al. (1991) Liver cell dysplasia and risk of hepatocellular carcinoma in cirrhosis: a preliminary report. Br. Med. J. 302, 1312.

    CAS  Google Scholar 

  33. Borzio, M., Bruno, S., Roncalli, M., Mels, G. C., Ramella, G., Borzio, F., et al. (1995) Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study. Gastroenterology. 108, 812–817.

    CAS  PubMed  Google Scholar 

  34. Watanabe, S., Okita, K., Harada, T., Kodama, T., Numa, Y., Takemoto, T., et al. (1983) Morphologic studies of the liver cell dysplasia. Cancer 51, 2197–2205.

    CAS  PubMed  Google Scholar 

  35. Nakanuma, Y., Kanel, G. C., Doishita, K., Ohta, G., and Peters, R. L. (1989) Risk lesions in cirrhosis and development of hepatocellular carcinoma: an autopsy study. Biomed. Pharmacother. 43, 127–133.

    CAS  PubMed  Google Scholar 

  36. Podda, M., Roncalli, M., Battezzati, P. M., Borzio, M., Bruno, S., Servida, E. et al. (1992) Liver-cell dysplasia and hepatocellular carcinoma. Ital. J. Gastroenterol. 24, 39–42.

    CAS  PubMed  Google Scholar 

  37. Farber, E. (1976) Hyperplastic areas, hyperplastic nodules, and hyperbasophilic areas as putative precursor lesions. Cancer Res. 36, 2532–2533.

    CAS  PubMed  Google Scholar 

  38. Farber, E. and Sarma, D. S. (1987) Hepatocarcinogenesis: a dynamic cellular perspective. Lab. Invest. 56, 4–22.

    CAS  PubMed  Google Scholar 

  39. Schirmacher, P., Held, W. A., Yang, D., Biempica, L., and Rogler, C. E. (1991) Selective amplification of periportal transitional cells precedes formation of hepatocellular carcinoma in SV40 large tag transgenic mice. Am. J. Pathol. 139, 231–241.

    CAS  PubMed  Google Scholar 

  40. Cullen, J. M., Sandgren, E. P., Brinster, R. L., and Maronpot, R. R. (1993) Histologic characterization of hepatic carcinogenesis in transgenic mice expressing SV40 T-antigens. Vet. Pathol. 30, 111–118.

    CAS  PubMed  Google Scholar 

  41. Geller, S. A., Nichols, W. S., Kim, S., Tolmachoff, T., Lee, S., Dycaico, M. J., et al. (1994) Hepatocarcinogenesis is the sequel to hepatitis in Z#2 alpha 1-antitrypsin transgenic mice: histopathological and DNA ploidy studies. Hepatology. 19, 389–397.

    CAS  PubMed  Google Scholar 

  42. Thorgeirsson, U. P., Gomez, D. E., Lindsay, C. K., Sinha, C. C., and Adamson, R. H. (1996) Liver tumors and possible preneoplastic lesions, induced by a food-derived heterocyclic amine in cynomolgus monkeys; a study of histology and cytokeratin expression. Liver. 16, 71–83.

    CAS  PubMed  Google Scholar 

  43. Ho, J. C., Wu, P. C., and Mak, T. K. (1981) Liver cell dysplasia in association with hepatocellularcarcinoma, cirrhosis and hepatitis B surface antigen in Hong Kong. Int. J. Cancer. 28, 571–574.

    CAS  PubMed  Google Scholar 

  44. Roncalli, M., Borzio, M., De Biagi, G., Ferrari, A. R., Macchi, R., Tombesi, V. M., et al. (1986) Liver cell dysplasia in cirrhosis. A serologic and immunohistochemical study. Cancer. 57, 1515–1521.

    CAS  PubMed  Google Scholar 

  45. Cohen, C. and Berson, S. D. (1986) Liver cell dysplasia in normal, cirrhotic, and hepatocellular carcinoma patients. Cancer. 57, 1535–1538.

    CAS  PubMed  Google Scholar 

  46. Omata, M., Mori, J., Yokosuka, O., Iwama, S., Ito, Y., and Okuda, K. (1982) Hepatitis B virus antigens in liver tissue in hepatocellular carcinoma and advanced chronic liver disease-relationship to liver cell dysplasia. Liver. 2, 125–132.

    CAS  PubMed  Google Scholar 

  47. Nakashima, T., Okuda, K., Kojiro, M., Jimi, A., Yamaguchi, R., Sakamoto, K., et al. (1983) Pathology of hepatocellular carcinoma in Japan. 232 consecutive cases autopsied in ten years. Cancer. 51, 863–877.

    CAS  PubMed  Google Scholar 

  48. Akagi, G., Furuya, K., Kanamura, A., Chihara, T., and Otsuka, H. (1984) Liver cell dysplasia and hepatitis B surface antigen in liver cirrhosis and hepatocellular carcinoma. Cancer 54, 315–318.

    CAS  PubMed  Google Scholar 

  49. Henmi, A., Uchida, T., and Shikata, T. (1985) Karyometric analysis of liver cell dysplasia and hepatocellular carcinoma. Evidence against precancerous nature of liver cell dysplasia. Cancer. 55, 2594–2599.

    CAS  PubMed  Google Scholar 

  50. Zhao, M. and Zimmermann, A. (1998) Liver cell dysplasia: reactivities for cmet protein, Rb protein, E-cadherin and transforming growth factor-beta 1 in comparison with hepatocellular carcinoma. Histol. Histopathol. 13, 657–670.

    CAS  PubMed  Google Scholar 

  51. Ganne-Carrié, N., Chastang, C., Chapel, F., Munz, C., Paterton, D., Sibony, M., et al. (1996) Predictive score for the development on hepatocellular carcinoma and additional value of live large cell dysplasia in western patients with cirrhosis. Hepatology. 23, 1112–1118.

    Google Scholar 

  52. Sakurai, M. (1978) Liver cell dysplasia and hepatitis B surface and core antigens in cirrhosis and hepatocellular carcinoma of autopsy cases. Acta Pathol. Jpn. 28, 705–719.

    CAS  PubMed  Google Scholar 

  53. Paterson, A. C., Kew, M. C., Duskeiko, G. M., and Isaacson, C. (1989) Liver cell dysplasia accompanying hepatocellular carcinoma in southern Africa. Differences between urban and rural populations. J. Hepatol. 8, 241–248.

    CAS  PubMed  Google Scholar 

  54. Theise, N. D., Schwartz, M., Miller, C., and Thung, S. N. (1992) Macroregenerative nodules and hepatocellular carcinoma in forty-four sequential adult liver explants with cirrhosis. Hepatology. 16, 949–955.

    CAS  PubMed  Google Scholar 

  55. Ojanguren, I., Castella, E., Ariza, A., Santos, J., Planas, R., and Bruguera, M. (1997) Liver cell atypias: a comparative study in cirrhosis with and without hepatocellular carcinoma. Histopathology. 30, 106–112.

    CAS  PubMed  Google Scholar 

  56. Lee, R. G., Tsamandas, A. C. and Demetris, A. J. (1997) Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched casecontrol study, pathological analysis, and pathogenetic hypothesis. Hepatology. 26, 1415–1422.

    CAS  PubMed  Google Scholar 

  57. Vandelli, C., Renzo, F., Floridia, A., Pifferi, M., Di Marco, G., Piccinini, L., et al. (1998) Hepatocellular carcinoma: role of viruses and liver cell dysplasia. Ital. J. Gastroenterol. Hepatol. 30(Suppl. 1), A70.

    Google Scholar 

  58. Beasley, R. P., Hwang, L. Y., Lin, C. C., and Chien, C. S. (1981) Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet. 2, 1129–1133.

    CAS  PubMed  Google Scholar 

  59. Oshima, A., Tsukuma, H., Hiyama, T., Fujimoto, I., Yamano, H., and Tanaka, M. (1984) Follow-up study of HBsAg-positive blood donors with special reference to effect of drinking and smoking on development of liver cancer. Int. J. Cancer 34, 775–779.

    CAS  PubMed  Google Scholar 

  60. Brechot, C., Pourcel, C., Louise, A., Rain, B., and Tiollais, P. (1980) Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature. 286, 533–535.

    CAS  PubMed  Google Scholar 

  61. Scaglioni, P. P., Melegari, M., and Wands, J. R. (1996) Recent advances in the molecular biology of hepatitis B virus. Baillieres Clin. Gastroenterol. 10, 207–225.

    CAS  PubMed  Google Scholar 

  62. Busuttil, R. W. and Farmer, D. G. (1996) The surgical treatment of primary hepatobiliary malignancy. Liver Transpl. Surg. 2, s114–s130.

    Google Scholar 

  63. Koike, K., Moriya, K., Iino, S., Yotsuyanagi, H., Endo, Y., Miyamura, T., et al. (1994) High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology. 19, 810–819.

    CAS  PubMed  Google Scholar 

  64. Kim, C. M., Koike, K., Saito, I., Miyamura, T., and Jay, G. (1991) HBx gene of hepatitis B virus induces liver cancer intransgenic mice. Nature 351, 317–320.

    CAS  PubMed  Google Scholar 

  65. Diamantis, I. D., McGandy, C. E., Chen, T. J., Liaw, Y. F., Gudat, F., and Bianchi, L. (1992) Hepatitis B X-gene expression in hepatocellular carcinoma. J. Hepatol. 15, 400–403.

    CAS  PubMed  Google Scholar 

  66. Takada, S., Tsuchida, N., Kobayashi, M., and Koike, K. (1995) Disruption of the function of tumor-suppressor gene p53 by the hepatitis B virus X protein and hepatocarcinogenesis. J. Cancer Res. Clin. Oncol. 12, 593–601.

    Google Scholar 

  67. Paterlini, P., Poussin, K. and De Mitri, S. (1994) Rate of persistence, structure, and expression of HBV genome in HCC developing in HBs-Ag negative patients, in Viral Hepatitis and Liver Disease (Nishioka, K. and Suzuki, H., eds. ), Springer-Verlag, Tokyo, pp.757–762.

    Google Scholar 

  68. Brechot, C. (1996) Hepatitis B and C viruses and primary liver cancer. Baillieres Clin Gastroenterol. 10, 335–373.

    CAS  PubMed  Google Scholar 

  69. Brechot, C. (1987) Hepatitis B virus (HBV) and hepatocellular carcinoma. HBV DNA status and its implications. J. Hepatol. 4, 269–279.

    CAS  PubMed  Google Scholar 

  70. Schimke, R. T. (1990) The search for early genetic events in tumorigenesis: an amplification paradigm. Cancer Cells. 2, 149–151.

    CAS  PubMed  Google Scholar 

  71. Slagle, B. L., Zhou, Y. Z., and Butel, J. S. (1991) Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas. Cancer Res. 51, 49–54.

    CAS  PubMed  Google Scholar 

  72. Takahashi, K., Kudo, J., Ishibashi, H., Hirata, Y., and Niho, Y. (1993) Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma. Hepatology. 17, 794–799.

    CAS  PubMed  Google Scholar 

  73. Bressac, B., Kew, M., Wands, J., and Ozturk, M. (1991) Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature. 350, 429–431.

    CAS  PubMed  Google Scholar 

  74. Harris, C. C. (1993) p53: at the crossroads of molecular carcinogenesis and risk assessment. Science. 262, 1980–1981.

    CAS  PubMed  Google Scholar 

  75. Solomon, E., Borrow, J., and Goddard, A. D. (1991) Chromosome aberrations and cancer. Science. 254, 1153–1160.

    CAS  PubMed  Google Scholar 

  76. Derynck, R., Goeddel, D. V., Ullrich, A., Gutterman, J. U., Williams, R. D., Bringman, T. S., et al. (1987) Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res. 47, 707–712.

    CAS  PubMed  Google Scholar 

  77. Hsia, C. C., Axiotis, C. A., Di Bisceglie, A. M., and Tabor, E. (1992) Transforming growth factor-alpha in human hepatocellular carcinoma and co-expression with hepatitis B surface antigen in adjacent liver. Cancer. 70, 1049–1056.

    CAS  PubMed  Google Scholar 

  78. Shirai, Y., Kawata, S., Ito, N., Tamura, S., Takaishi, K., Kiso, S., et al. (1992) Elevated levels of plasma transforming growth factor-beta in patients with hepatocellular carcinoma. Jpn. J. Cancer Res. 83, 676–679.

    CAS  PubMed  Google Scholar 

  79. Mead, J. E. and Fausto, N. (1989) Transforming growth factor a may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc. Natl. Acad. Sci. USA 86, 1558–1562.

    CAS  PubMed  Google Scholar 

  80. Yeh, J. and Yeh, Y. C. (1989) Transforming growth factor-alpha and human cancer. Biomed. Pharmacother. 43, 651–659.

    CAS  PubMed  Google Scholar 

  81. Sherlock, S. (1994) Viruses and hepatocellular carcinoma. Gut. 35, 828–832.

    CAS  PubMed  Google Scholar 

  82. Terris, B., Ingster, O., Rubbia, L., Dubois, S., Belghiti, J., Feldmann, G., et al. (1997) Interphase cytogenetic analysis reveals numerical chromosome aberrations in large liver cell dysplasia. J. Hepatol. 27, 313–319.

    CAS  PubMed  Google Scholar 

  83. Colombo, M., Kuo, G., Choo, Q. L., Donato, M. F., Del Ninno, E., Tommasini, M. A., et al. (1989) Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet. 2, 1006–1008.

    CAS  PubMed  Google Scholar 

  84. Simonetti, R. G., Cottone, M., Craxì, A., Pagliaro, L., Rapicetta, M., Chionne, P., et al. (1989) Prevalence of antibodies to hepatitis C virus in hepatocellular carcinoma. Lancet. 2, 1338.

    CAS  PubMed  Google Scholar 

  85. Levrero, M., Tagger, A., Balsano, C., De Marzio, E., Avantaggiati, M. L., Natoli, G., et al. (1991) Antibodies to hepatitis C virus in patients with hepatocellular carcinoma. J. Hepatol. 12, 60–63.

    CAS  PubMed  Google Scholar 

  86. Caporaso, N., Romano, M., Marmo, R., De Sio, I., Morisco, F., Minerva, A., et al. (1991) Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis. J. Hepatol. 12, 367–371.

    CAS  PubMed  Google Scholar 

  87. Bruix, J., Barrera, J. M., Calvet, X., Ercilla, G., Costa, J., Sanchez-Tapias, J. M., et al. (1989) Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet. 2, 1004–1006.

    CAS  PubMed  Google Scholar 

  88. Kew, M. C., Houghton, M., Choo, Q. L., and Kuo, G. (1990) Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma. Lancet. 2, 873–874.

    Google Scholar 

  89. Kiyosawa, K. and Furuta, S. (1991) Review of hepatitis C in Japan. J. Gastroenterol. Hepatol. 6, 383–391.

    CAS  PubMed  Google Scholar 

  90. Gentilini, P., Melani, L., Riccardi, D., Casini Raggi, V., and Romanelli, R. G. (1994) Hepatocellular carcinoma and viral cirrhosis. Hepatology. 20, 764–765.

    CAS  PubMed  Google Scholar 

  91. Muchmore, E., Popper, H., Peterson, D. A., Miller, M. F., and Lieberman, H. M. (1988) Non-A, non-B hepatitis-related hepatocellular carcinoma in a chimpanzee. J. Med. Primatol. 17, 235–346.

    CAS  PubMed  Google Scholar 

  92. Diamantis, I. D., McGandy, C. E., Chen, T. J., Liaw, Y. F., Gudat, F., and Bianchi, L. (1994) Detection of hepatitis B and C viruses in liver tissue with hepatocellular carcinoma. J. Hepatol. 20, 405–409.

    CAS  PubMed  Google Scholar 

  93. De Mitri, M. S., Poussin, K., Baccarini, P., Pontisso, P., D’Errico, A., Simon, N., et al. (1995) HCV-associated liver cancer without cirrhosis. Lancet. 1, 413–415.

    Google Scholar 

  94. el-Refaie, A., Savage, K., Bhattacharya, S., Khakoo, S., Harrison, T. J., el-Batanony, M., et al. (1996) HCV-associated hepatocellular carcinoma without cirrhosis. J. Hepatol. 24, 277–285.

    CAS  PubMed  Google Scholar 

  95. Moradpour, D. and Wand, J. R. (1996) Hepatic oncogenesis, in Hepatology a Textbook of Liver Disease, 3rd ed. (Zakim, D. and Boyer, T. D., eds. ), WB Saunders, Philadelphia, pp.1490–1512.

    Google Scholar 

  96. Ferrell, L., Wright, T., Lake, J., Roberts, J., and Ascher, N. (1992) Incidence and diagnostic features of macroregenerative nodules vs. small hepatocellular carcinoma in cirrhotic livers. Hepatology. 16, 1372–1381.

    CAS  PubMed  Google Scholar 

  97. Orsatti, G., Theise, N. D., Thung, S. N., and Paronetto, F. (1993) DNA image cytometric analysis of macroregenerative nodules (adenomatous hyperplasia) of the liver: evidence in support of their preneoplastic nature. Hepatology. 17, 621–627.

    CAS  PubMed  Google Scholar 

  98. Tanaka, S., Takenaka, K., Matsumata, T., Mori, R., and Sugimachi, K. (1996) Hepatitis C virus replication is associated with expression of transforming growth factor-alpha and insulin-like growth factor-II in cirrhotic livers. Dig. Dis. Sci. 41, 208–215.

    CAS  PubMed  Google Scholar 

  99. Sakamuro, D., Furukawa, T., and Takegami, T. (1995) Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J. Virol. 69, 3893–3896.

    CAS  PubMed  Google Scholar 

  100. Ray, R. B., Lagging, L. M., Meyer, K., and Ray, R. (1996) Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J. Virol. 70, 4438–4443.

    CAS  PubMed  Google Scholar 

  101. Matsumoto, M., Zhu, N., and Hwang, S. B. (1995) Interactions of hepatitis C virus core protein with members of tumor necrosis factor receptor family: implication for HCV persistency and pathogenesis. Intl. Symposium on Hepatitis C Virus and Related Viruses, paper C48.

    Google Scholar 

  102. Hagiwara, H., Hayashi, N., Mita, E., Hiramatsu, N., Ueda, K., Takehara, T., et al. (1992) Detection of hepatitis C virus RNA in chronic non-A, non-B liver disease. Gastroenterology. 102, 692–694.

    CAS  PubMed  Google Scholar 

  103. Ruiz, J., Sangro, B., Cuende, J. I., Beloqui, O., Riezu-Boj, J. I., Herrero, J. I., et al. (1992) Hepatitis B and C viral infections in patients with hepatocellular carcinoma. Hepatology. 16, 637–641.

    CAS  PubMed  Google Scholar 

  104. Sheu, J. C., Huang, G. T., Shih, L. N., Lee, W. C., Chou, H. C., Wang, J. T., et al. (1992) Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma. Gastroenterology. 103, 1322–1327.

    CAS  PubMed  Google Scholar 

  105. Takeda, S., Shibata, M., Morishima, T., Harada, A., Nakao, A., Takagi, H., et al. (1992) Hepatitis C virus infection in hepatocellular carcinoma. Detection of plus-strand and minus-strand viral RNA. Cancer. 70, 2255–2259.

    CAS  PubMed  Google Scholar 

  106. Thelu, M. A., Zarski, J. P., Dardelet, D., Lunel, F., and Seigneurin, J. M. (1992) Low prevalence of hepatitis C virus genome detected by PCR in serum of Caucasian patients with hepatocellular carcinoma. J. Hepatol. 14, 415–416.

    CAS  PubMed  Google Scholar 

  107. Benvegnù, L., Fattovich, G., Diodati, G., Noventa, F., Pontisso, P., Tremolada, F., et al. (1993) Hepatitis C virus infection and replication in patient with hepatocellular carcinoma. In Viral Hepatitis and Liver Disease (Nishioka, K., Suzuki, H., Mishiro, S., and Oda, T. eds.), Springer-Verlag, Tokyo. pp. 706–709.

    Google Scholar 

  108. Bukh, J., Miller, R. H., Kew, M. C., and Purcell, R. H. 1993 Hepatitis C virus RNA in southern African blacks with hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 90, 1848–1851.

    Google Scholar 

  109. Mangia, A., Vallari, D. S., and Di Bisceglie, A. M. (1994) Use of confirmatory assays for diagnosis of hepatitis C viral infection in patients with hepatocellular carcinoma. J. Med. Virol. 43, 125–128.

    CAS  PubMed  Google Scholar 

  110. Oka, H., Yamamoto, S., Kuroki, T., Harihara, S., Marumo, T., Kim, S. R., et al. (1995) Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9). Cancer. 76, 743–749.

    CAS  PubMed  Google Scholar 

  111. Vandelli, C., Piaggi, V., Palmisani, L., Renzo, F., Di Marco, G., Floridia, A., et al. (1992) Histological and morphological evolution of anti HCV correlated liver damage. J. Hepatol. 17(Suppl. 1), S31.

    Google Scholar 

  112. Oka, H., Kurioka, N., Kim, K., Kanno, T., Kuroki, T., Mizoguchi, Y., et al. (1990) Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology. 12, 680–687.

    CAS  PubMed  Google Scholar 

  113. Sato, Y., Nakata, K., Kato, Y., Shima, M., Ishii, N., Koji, T., et al. (1993) Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. N. Engl. J. Med. 328, 1802–1806.

    CAS  PubMed  Google Scholar 

  114. Cottone, M., Turri, M., Caltagirone, M., Parisi, P., Orlando, A., Fiorentino, G., et al. (1994) Screening for hepatocellular carcinoma in patients with Child’s A cirrhosis: an 8-year prospective study by ultrasound and alphafetoprotein. J. Hepatol. 2, 1029–1034.

    Google Scholar 

  115. Pateron, D., Ganne, N., Trinchet, J. C., Aurousseau, M. H., Mal, F., Meicler, C., et al. (1994) Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J. Hepatol. 20, 65–71.

    CAS  PubMed  Google Scholar 

  116. Kaklamani, E., Trichopoulos, D., Tzonou, A., Zavitsanos, X., Koumantaki, Y., Hatzakis, A., et al. (1991) Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA 265, 1974–1976.

    CAS  PubMed  Google Scholar 

  117. Simonetti, R. G., Camma, C., Fiorello, F., Cottone, M., Rapicetta, M., Marino, L., et al. (1992) Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann. Intern. Med. 116, 97–102.

    CAS  PubMed  Google Scholar 

  118. Benvegnù, L., Fattovich, G., Noventa, F., Tremolada, F., Chemello, L., Cecchetto, A., et al. (1994) Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer 74, 2442–2448.

    PubMed  Google Scholar 

  119. Szczepanski, W. (1997) Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma. Pol. J. Pathol. 48, 147–157.

    CAS  PubMed  Google Scholar 

  120. Furuya, K., Nakamura, M., Yamamoto, Y., Togei, K., and Otsuka, H. (1988) Macroregenerative nodule of the liver. A clinicopathologic study of 345 autopsy cases of chronic liver disease. Cancer 61, 99–105.

    CAS  PubMed  Google Scholar 

  121. Craig, J. R., Klatt, E. C., and Yu, M. (1991) Role of cirrhosis and the development of HCC, in Etiology, Patology, and Treatment of Hepatocellular Carcinoma in North America (Tabor, E., Di Bisceglie, A. M., and Purcell, R. H. eds.), The Woodlands, Portfollo Publishing, pp. 177–190.

    Google Scholar 

  122. Cohen, C. and Derose, P. B. (1994) Liver cell dysplasia in alpha-1-antitrypsin deficiency. Mod. Pathol. 7, 31–36.

    CAS  PubMed  Google Scholar 

  123. Riegler, J. L. (1996) Preneoplastic conditions of the liver. Semin. Gastrointest. Dis. 7, 74–87.

    CAS  PubMed  Google Scholar 

  124. Idilman, R., De Maria, N., Colantoni, A., and Van Thiel, D. H. (1998) Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma. J. Viral. Hepat. 5, 285–299.

    CAS  PubMed  Google Scholar 

  125. Kew, M. C. (1994) Hepatitis C virus and hepatocellular carcinoma. FEMS Microbiol. Rev. 14, 211–219.

    CAS  PubMed  Google Scholar 

  126. Gerber, M. A., Shieh, Y. S., Shim, K. S., Thung, S. N., Demetris, A. J., Schwartz, M., et al. (1992) Detection of replicative hepatitis C virus sequences in hepatocellular carcinoma. Am. J. Pathol. 141, 1271–1277.

    CAS  PubMed  Google Scholar 

  127. Horiike, N., Nonaka, T., Kumamoto, I., Kajino, K., Onji, M., and Ohta, Y. (1993) Hepatitis C virus plus-and minus-strand RNA in hepatocellular carcinoma and adjoining nontumorous liver. J. Med. Virol. 41, 312–315.

    CAS  PubMed  Google Scholar 

  128. Takamizawa, A., Mori, C., Fuke, I., Manabe, S., Murakami, S., Fujita, J., et al. (1991) Structure and organization of the hepatitis C virus genome isolated from human carriers. J. Virol. 65, 1105–1113.

    CAS  PubMed  Google Scholar 

  129. Teramoto, T., Satonaka, K., Kitazawa, S., Fujimori, T., Hayashi, K., and Maeda, S. (1994) p53 Gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis. Cancer Res. 54, 231–235.

    CAS  PubMed  Google Scholar 

  130. Adachi, E., Hashimoto, H., and Tsuneyoshi, M. (1993) Proliferating cell nuclear antigen in hepatocellular carcinoma and small cell liver dysplasia. Cancer. 72, 2902–2909.

    CAS  PubMed  Google Scholar 

  131. Shibata, M., Morizane, T., Uchida, T., Yamagami, T., Onozuka, Y., Nakano, M., et al. (1998) Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection. Lancet. 1, 1773–1777.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento Medicina Interna, Modena University, Modena, Italy

    Carmen Vandelli & Francesco Renzo

Authors
  1. Carmen Vandelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francesco Renzo
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Liver Surgery Section, Imperial College School of Medicine, Hammersmith Hospital, London, UK

    Nagy A. Habib

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Humana Press Inc., Totowa, NJ

About this protocol

Cite this protocol

Vandelli, C., Renzo, F. (2000). Hepatocellular Carcinoma. In: Habib, N.A. (eds) Hepatocellular Carcinoma. Methods in Molecular Medicine™, vol 45. Humana Press. https://doi.org/10.1385/1-59259-079-9:71

Download citation

  • DOI: https://doi.org/10.1385/1-59259-079-9:71

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-785-4

  • Online ISBN: 978-1-59259-079-7

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation